FilingSEC EDGARSCHEDULE 13GArriVent BioPharma, Inc. filed Form SCHEDULE 13GOct 13, 2026, 16:01 ET · SEC acceptedSummaryFiling infoView sourceFiling contentPlease check the source for details.Related companiesArriVent BioPharma, Inc.AVBPView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…